Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradigm of autism spectrum disorders targeting nitric oxide pathway. - Mehta R; Bhandari R; Kuhad A (Metabolic brain disease, 2021)